Eads & Heald Wealth Management Pfizer Inc Transaction History

Eads & Heald Wealth Management

$211 Million
Q3 2024

A detailed history of Eads & Heald Wealth Management transactions in Pfizer Inc stock. As of the latest transaction made, Eads & Heald Wealth Management holds 8,858 shares of PFE stock, worth $234,028. This represents 0.12% of its overall portfolio holdings.

Number of Shares

8,858

Previous 8,813 0.51%

Holding current value

$234,028

Previous $246,000 4.07%

% of portfolio

0.12%

Previous 0.12%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$27.7 - $31.39 $1,246 - $1,412	45 Added 0.51%	8,858 $256,000
Q2 2024 Jul 23, 2024	BUY	$25.26 - $29.6 $28,316 - $33,181	1,121 Added 14.57%	8,813 $246,000
Q1 2024 Apr 23, 2024	SELL	$25.89 - $29.73 $11,650 - $13,378	-450 Reduced 5.53%	7,692 $213,000
Q4 2023 Jan 30, 2024	SELL	$26.13 - $33.94 $125,502 - $163,013	-4,803 Reduced 37.1%	8,142 $234,000
Q3 2023 Oct 27, 2023	SELL	$32.09 - $37.51 $99,158 - $115,905	-3,090 Reduced 19.27%	12,945 $429,000
Q2 2023 Jul 25, 2023	BUY	$36.12 - $41.79 $145,744 - $168,622	4,035 Added 33.63%	16,035 $588,000
Q1 2023 Apr 21, 2023	BUY	$39.39 - $51.28 $177,964 - $231,683	4,518 Added 60.38%	12,000 $490,000
Q4 2022 Jan 27, 2023	SELL	$41.75 - $54.5 $5,845 - $7,630	-140 Reduced 1.84%	7,482 $383,000
Q3 2022 Oct 27, 2022	SELL	$43.76 - $53.42 $32,382 - $39,530	-740 Reduced 8.85%	7,622 $333,000
Q2 2022 Jul 26, 2022	SELL	$46.53 - $55.17 $15,820 - $18,757	-340 Reduced 3.91%	8,362 $438,000
Q1 2022 Apr 27, 2022	SELL	$45.75 - $56.69 $104,035 - $128,913	-2,274 Reduced 20.72%	8,702 $450,000
Q4 2021 Jan 31, 2022	SELL	$41.32 - $61.25 $26,610 - $39,445	-644 Reduced 5.54%	10,976 $648,000
Q3 2021 Oct 27, 2021	SELL	$39.25 - $50.42 $392 - $504	-10 Reduced 0.09%	11,620 $499,000
Q2 2021 Jul 30, 2021	BUY	$35.91 - $40.68 $7,002 - $7,932	195 Added 1.71%	11,630 $455,000
Q1 2021 Apr 29, 2021	BUY	$33.49 - $37.77 $40,656 - $45,852	1,214 Added 11.88%	11,435 $414,000
Q3 2020 Nov 02, 2020	BUY	$31.75 - $37.25 $18,415 - $21,605	580 Added 6.02%	10,221 $355,000
Q2 2020 Jul 29, 2020	SELL	$30.12 - $36.54 $753 - $913	-25 Reduced 0.26%	9,641 $299,000
Q1 2020 May 01, 2020	BUY	$27.03 - $38.62 $8,514 - $12,165	315 Added 3.37%	9,666 $299,000
Q4 2019 Jan 31, 2020	BUY	$32.92 - $37.36 $8,065 - $9,153	245 Added 2.69%	9,351 $347,000
Q3 2019 Oct 31, 2019	BUY	$32.49 - $42.13 $295,853 - $383,635	9,106 New	9,106 $310,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eads & Heald Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Eads & Heald Wealth Management with notifications on news.

Account

Eads & Heald Wealth Management Pfizer Inc Transaction History